Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2017

01-07-2017 | Original Paper

Evolution of Monitoring and Evaluation of AIDS Response in Ukraine: Laying the Groundwork for Evidence-Based Health Care

Authors: Kostyantyn Dumchev, Olga Varetska, Ihor Kuzin

Published in: AIDS and Behavior | Special Issue 1/2017

Login to get access

Abstract

Once facing the most severe HIV epidemic in Eastern Europe, Ukraine has built an elaborate Monitoring and Evaluation (M&E) system to track the response to AIDS. This system was developed using recommendations and input from multiple international expert organizations and donors and, at the current stage, serves as a best practice model in many areas. The present paper aims to provide a comprehensive overview of the evolution of the M&E system in Ukraine since its inception. Notable achievements and challenges are described and illustrated by epidemiological data and the recommendations for future development are discussed. Unique experiences and advances in M&E in Ukraine may be useful to other countries facing similar epidemiological, structural or methodological issues.
Literature
1.
Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP. The most severe HIV epidemic in Europe: Ukraine’s national HIV prevalence estimates for 2007. Sex Transm Infect. 2008;84(Suppl 1):i37–41.CrossRefPubMedPubMedCentral
2.
3.
Vitek CR, Cakalo JI, Kruglov YV, Dumchev KV, Salyuk TO, Bozicevic I, et al. Slowing of the HIV epidemic in Ukraine: evidence from case reporting and key population surveys, 2005–2012. PLoS One. 2014;9(9):e103657.CrossRefPubMedPubMedCentral
4.
Andrushchak LI. The prevention of HIV infection and STDs among injection drug addicts in Ukraine. Zh Mikrobiol Epidemiol Immunobiol. 1999;1:86–9.
5.
6.
7.
Baughman L, Qualls N. Capacity assessment of the National HIV Monitoring and Evaluation Center in Ukraine. CDC/CGH/DGHA, 2011.
8.
9.
10.
On monitoring and evaluation of national indicators on effectiveness of measures to control HIV/AIDS epidemic. Directive #890-p of 13-12-2004. Cabinet of Ministers of Ukraine; 2004.
11.
Donoghoe MC, Verster A, Pervilhac C, Williams P. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance. Int J Drug Policy. 2008;19(Suppl 1):S5–14.CrossRefPubMed
12.
WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users—2012 revision. 2012 978 92 4 150437 9.
13.
14.
On single system of monitoring and evaluation of measures on containment of HIV/AIDS epidemic. Directive #1349 of 28-12-2011. Cabinet of Ministers of Ukraine; 2011.
15.
16.
Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting of HIV transmission among men who have sex with men in the Ukraine. AIDS Res Hum Retroviruses. 2014;30(5):407–8.CrossRefPubMedPubMedCentral
17.
18.
19.
Denisiuk O, Smyrnov P, Kumar AM, Achanta S, Boyko K, Khogali M, et al. Sex, drugs and prisons: HIV prevention strategies for over 190 000 clients in Ukraine. Public Health Action. 2014;4(2):96–101.CrossRefPubMedPubMedCentral
20.
Dumchev K, Varetska O, Samko M. Prevention program data indicate low HIV incidence among people who use drugs in Ukraine. 20th International AIDS Conference; Melbourne, Australia: Poster #WEPE168; 2014.
21.
Samko M, Dumchev K. Evaluation of HIV prevention impact on seroconversion using a combination of retrospective and prospective study designs. 20th International AIDS Conference; Melbourne, Australia Poster #THPE106; 2014.
22.
WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for second generation HIV surveillance: an update: know your epidemic. Geneva: World Health Organization; 2013.
23.
24.
Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012;7(3):e33328.CrossRefPubMedPubMedCentral
25.
Dumchev K, Salyuk T, Sazonova YO. Three rounds of integrated bio-behavioral surveillance confirm declining HIV prevalence among people who inject drugs (PWID) in Ukraine. International Forum of the National Institute on Drug Abuse; 15-06-2015; Phoenix, AZ: Poster #218; 2015.
26.
27.
Smyrnov P, Broadhead RS, Datsenko O, Matiyash O. Rejuvenating harm reduction projects for injection drug users: Ukraine’s nationwide introduction of peer-driven interventions. Int J Drug Policy. 2012;23(2):141–7.CrossRefPubMed
28.
Mazhnaya A, Andreeva TI, Samuels S, DeHovitz J, Salyuk T, McNutt LA. The potential for bridging: HIV status awareness and risky sexual behaviour of injection drug users who have non-injecting permanent partners in Ukraine. J Int AIDS Soc. 2014;17:18825.CrossRefPubMedPubMedCentral
29.
McCreesh N, Copas A, Seeley J, Johnston LG, Sonnenberg P, Hayes RJ, et al. Respondent driven sampling: determinants of recruitment and a method to improve point estimation. PLoS One. 2013;8(10):e78402.CrossRefPubMedPubMedCentral
30.
Artyukh OR, Balakireva OM, Bochkova LV, Galilch YP, Galustyan YM, Dikova-Favorska DM, et al. Behaviour surveillance of injecting drug user populations as a component of the second generation HIV surveillance. Kiev: International HIV/AIDS Alliance in Ukraine; 2005.
31.
32.
33.
Dumchev K, Berleva G, Varetska O. Estimating the number of people who inject drugs in Ukraine: a decade of experience. 24th International Harm Reduction Conference; Kuala Lumpur, Malaysia: Poster #423; 2015.
34.
35.
Dvoriak S, Karachevsky A, Chhatre S, Booth R, Metzger D, Schumacher J, et al. Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response. Drug Alcohol Depend. 2014;137:62–7.CrossRefPubMedPubMedCentral
36.
Nerlander LM, Zapata LB, Yorick R, Skipalska H, Smith RA, Kissin DM, et al. Behaviors Associated With a Risk of HIV Transmission From HIV-Positive Street Youth to Non-Street Youth in Ukraine. Sex Transm Dis. 2015;42(9):513–20.CrossRefPubMed
37.
38.
39.
40.
Metadata
Title
Evolution of Monitoring and Evaluation of AIDS Response in Ukraine: Laying the Groundwork for Evidence-Based Health Care
Authors
Kostyantyn Dumchev
Olga Varetska
Ihor Kuzin
Publication date
01-07-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1571-y

Other articles of this Special Issue 1/2017

AIDS and Behavior 1/2017 Go to the issue

Original Paper

Monitoring HIV Treatment and the Health Sector Cascade: From Treatment Numbers to Impact

OriginalPaper

Investing for Impact: The Global Fund Approach to Measurement of AIDS Response

Original Paper

Prevention of Mother-to-Child Transmission of HIV and Paediatric HIV Care and Treatment Monitoring: From Measuring Process to Impact and Elimination of Mother-to-Child Transmission of HIV

Original Paper

The Role of Civil Society Organizations in Monitoring the Global AIDS Response

Original Paper

Social Media Monitoring of Discrimination and HIV Testing in Brazil, 2014–2015

Original Paper

Monitoring HIV-Related Laws and Policies: Lessons for AIDS and Global Health in Agenda 2030
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits